Oncorus®, Inc., Presents Preclinical Data on Next-Generation Oncolytic Virus Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting

CAMBRIDGE, Mass., March 15, 2018 /PRNewswire/ -- Oncorus®, Inc., a biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses for the treatment of several tumor types, today announced that preclinical data on its oncolytic Herpes Simplex Virus (oHSV)...